Full Text View
Tabular View
No Study Results Posted
Related Studies
Femoral Arterial Access With Ultrasound Trial (FAUST)
This study has been completed.
Study NCT00667381   Information provided by University of California, Irvine
First Received: April 24, 2008   Last Updated: August 14, 2009   History of Changes

April 24, 2008
August 14, 2009
April 2008
February 2009   (final data collection date for primary outcome measure)
Successful common femoral artery cannulation, as determined by femoral angiography. [ Time Frame: Immediately, during procedure. ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00667381 on ClinicalTrials.gov Archive Site
  • Time to successful sheath insertion. [ Time Frame: Immediate ] [ Designated as safety issue: No ]
  • Number of femoral venipunctures. [ Time Frame: Immediate ] [ Designated as safety issue: Yes ]
  • Vascular complications, including bleeding, thrombosis, dissection, transfusion. [ Time Frame: Immediate and up to 1 month after procedure. ] [ Designated as safety issue: Yes ]
Same as current
 
Femoral Arterial Access With Ultrasound Trial
Femoral Arterial Access With Ultrasound Trial

This study is designed to evaluate the routine use of vascular ultrasound as an aid for proper placement of a femoral arterial sheath during cardiac catheterization and peripheral arterial angiography.

Cardiac catheterization is conventionally performed with femoral arterial access using a combination of arterial pulse palpation, anatomical landmarks, and fluoroscopic landmarks to guide needle insertion. Vascular access complications including hematoma formation, retroperitoneal bleeding, and arterial dissection are the most common types of adverse events associated with cardiac catheterization, and have been associated with insertions above and below the level of the common femoral artery. Real-time ultrasound assistance for central venous catheter placement has been proven in multiple studies to reduce complications, and has been recommended by the Agency for Healthcare Research and Quality as a "Top 11 Highly Proven" patient safety practice. This recommendation has not yet been extended to arterial access, due to a lack of studies to date. However, ultrasound assistance is licensed for and commonly utilized for arterial access, especially in difficult patients.

In a pilot study of 71 procedures performed by the lead researcher, ultrasound guidance was associated with an improved 1st pass success rate (83% vs 47%, p=0.002), reduced risk of accidental venipunctures (0% vs 25%, p=0.002), and greater overall success in common femoral artery cannulation (89% vs 69%, p=0.048) as compared with the fluoroscopic control.

This study is a multicenter prospective randomized trial to generalize the above findings with more patients studied, a larger number of operators, and across several centers. Similar to the previous study, the ultrasound will be used real-time to visualize the femoral vein, femoral artery, and needle tract as the needle is inserted, to guide the needle towards the appropriate location in the artery. The time for insertion, number of passes, complications, and position of the insertion catheter on the femoral angiogram will be analyzed in the setting of patient factors including age, body mass index, and presence of peripheral vascular disease.

 
Interventional
Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study
  • Vascular Access Complications
  • Cardiac Catheterization
  • Peripheral Vascular Disease
Device: Real-time Ultrasound Guidance (Site-Rite 5 or 6 machine)
  • No Intervention: The combination of anatomic landmarks and fluoroscopic localization of the femoral head will be used to guide femoral arterial access.
  • Experimental: Patients randomized to Ultrasound will have anatomic landmarks checked and real-time ultrasound guidance to aid femoral arterial access.
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
1004
March 2009
February 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Adults age 18 and over
  • Patients undergoing left heart catheterization or peripheral arterial angiography from the retrograde femoral approach
  • Willingness and ability to sign consent form
  • Scheduled to have procedure performed by operator trained in the ultrasound technique

Exclusion Criteria:

  • Access from a site other than the common femoral artery
  • Nonpalpable femoral pulses
  • Creatinine > 3.0 mg/dl, unless already on dialysis
  • Prisoners
  • Pregnant women
  • Unable or refusal to sign consent form
  • Patients undergoing emergent cardiac catheterization for ST segment elevation myocardial infarction or unstable acute coronary syndrome
  • Equipment unavailable
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00667381
Arnold Seto, University of California, Irvine
HS# 2007-5989
University of California, Irvine
  • C. R. Bard
  • University of Oklahoma
  • Department of Veterans Affairs
  • Long Beach Memorial Medical Center
Principal Investigator: Arnold H Seto, MD, MPA University of California, Irvine
Principal Investigator: Morton Kern, MD University of California, Irvine
Principal Investigator: Mazen Abu-Fadel, MD Oklahoma Veteran's Administration Medical Center
University of California, Irvine
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP